Edwards Lifesciences Corporation Stock
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
16:00:03 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 88.26 USD | +0.01% |
|
+4.61% | +3.53% |
| 09-16 | Edwards Lifesciences Corporation Presents at Deutsche Bank 2026 Healthcare Summit, Sep-16-2026 10:00 AM | |
| 09-11 | Edwards Lifesciences Reaffirms 2026 Guidance Following Medicare TAVR Decision | MT |
| Market Cap | 50.87B 44.36B 41.89B 38.04B 71.27B 4,882B 71.56B 502B 194B 2,482B 191B 187B 7,986B | P/E 2026 * |
34.9x | P/E 2027 * | 26.7x |
|---|---|---|---|---|---|
| Enterprise Value | 47.24B 41.2B 38.9B 35.32B 66.18B 4,533B 66.46B 466B 180B 2,305B 177B 174B 7,416B | EV / Sales 2026 * |
6.99x | EV / Sales 2027 * | 6.15x |
| Free-Float |
86.96% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EW | Delayed | |
CBOE
| EW | Real-time | |
Mexican S.E.
| EW * | End-of-day quote | |
Tradegate
| EWL | Real-time | |
Xetra
| EWL | Delayed | |
Börse Stuttgart
| EWL | Delayed | |
Boerse Muenchen
| EWL | Real-time | |
Deutsche Boerse AG
| EWL | Delayed | |
Wiener Boerse
| EWLS | End-of-day quote | |
Borsa Italiana
| 1EW | End-of-day quote | |
Swiss Exchange
| EW | Delayed | |
Swiss Exchange
| EW | Delayed | |
CBOE
| 0REN | Real-time | |
CBOE
| Real-time |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | +0.01% | ||
| 1 week | +4.61% | ||
| Current month | -2.74% | ||
| 1 month | -1.75% | ||
| 3 months | +1.03% | ||
| 6 months | +6.98% | ||
| Current year | +3.53% |
| 1 week | 84.47 | 89.7 | |
| 1 month | 83.81 | 92.95 | |
| Current year | 74.66 | 96.29 | |
| 1 year | 72.3 | 96.29 | |
| 3 years | 58.93 | 96.29 | |
| 5 years | 58.93 | 131.73 | |
| 10 years | 27.04 | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2023-05-10 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 2026-05-28 |
| Chief Tech/Sci/R&D Officer | 51 | 2025-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 2024-05-06 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 2015-02-09 |
| Director/Board Member | 58 | 2023-05-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/14/26 | Tax | Executive/Senior Manager | -568 | 0.0001% | ||
| 9/13/26 | Tax | Controller/Auditor | -253 | 0.0000% | ||
| 9/11/26 | Tax | Executive/Senior Manager | -398 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.01% | +4.61% | +18.61% | +22.67% | 50.87B | ||
| -1.04% | +6.83% | +35.84% | +29.03% | 241B | ||
| -0.32% | +5.83% | +9.58% | -16.76% | 149B | ||
| +2.55% | +6.55% | -10.35% | +34.72% | 139B | ||
| -0.48% | +0.84% | -55.70% | -19.89% | 62.81B | ||
| -1.69% | -1.20% | -19.89% | -17.59% | 48.21B | ||
| +0.08% | +6.49% | +23.87% | +39.12% | 44.11B | ||
| -1.88% | +3.25% | +40.14% | +53.82% | 41.42B | ||
| -2.27% | +16.07% | +133.21% | +73.20% | 36.18B | ||
| -1.50% | +3.08% | -17.64% | +59.43% | 32.19B | ||
| Average | -0.65% | +5.24% | +15.77% | +25.77% | 84.45B | |
| Weighted average by Cap. | -0.31% | +5.63% | +14.30% | +20.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.76B 5.89B 5.57B 5.05B 9.47B 649B 9.51B 66.67B 25.73B 330B 25.39B 24.83B 1,061B | 7.43B 6.48B 6.12B 5.55B 10.41B 713B 10.45B 73.27B 28.27B 362B 27.91B 27.29B 1,166B |
| Net income | 1.44B 1.25B 1.18B 1.07B 2.01B 138B 2.02B 14.15B 5.46B 70.01B 5.39B 5.27B 225B | 1.9B 1.65B 1.56B 1.42B 2.66B 182B 2.67B 18.71B 7.22B 92.53B 7.12B 6.97B 298B |
| Net Debt | -3.63B -3.17B -2.99B -2.71B -5.09B -348B -5.11B -35.81B -13.82B -177B -13.64B -13.34B -570B | -5.19B -4.53B -4.28B -3.88B -7.28B -498B -7.31B -51.23B -19.77B -253B -19.51B -19.08B -815B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-18 | US$88.26 | +0.01% | 4,258,353 |
| 26-09-17 | US$88.25 | -1.15% | 3,880,110 |
| 26-09-16 | US$89.28 | +4.13% | 5,011,766 |
| 26-09-15 | US$85.74 | +0.26% | 3,777,847 |
| 26-09-14 | US$85.52 | +1.36% | 2,988,117 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions

















